Berlin, Germany

Hartmut Kuhn

This inventor holds 1 USPTO granted patent. Top assignee: Veb Arzneimittelwerk Dresden. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hartmut Kuhn. Retrieved from https://idiyas.com/inventor/hartmut-kuhn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hartmut Kuhn: Innovator in Pharmaceutical Chemistry

Introduction

Hartmut Kuhn is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds with valuable pharmacological properties.

Latest Patents

Kuhn holds a patent for "Hydroxamic acid and pharmaceutical preparations containing the same." This patent describes new .omega.(2'-naphthoxy)-alkylhydroxamic acids and a process for their production. The compounds exhibit antiasthmatic properties and other pharmacologically valuable characteristics. They are synthesized by reacting the corresponding carboxylic acid ester or amide with hydroxylamine or its salt under specific conditions, resulting in compounds of Formula I.

Career Highlights

Kuhn has worked at Veb Arzneimittelwerk Dresden, where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical preparations, particularly those aimed at treating respiratory conditions.

Collaborations

Throughout his career, Kuhn has collaborated with notable colleagues, including Samuel M Rapoport and Jurgen Slapke. These collaborations have fostered a productive environment for innovation and research in pharmaceutical chemistry.

Conclusion

Hartmut Kuhn's contributions to the field of pharmaceutical chemistry, particularly through his patent on hydroxamic acids, highlight his role as an innovator. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…